BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8617766)

  • 1. Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes.
    Hermida-Matsumoto ML; Chock PB; Curran T; Yang DC
    J Biol Chem; 1996 Mar; 271(9):4930-6. PubMed ID: 8617766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitinylation and ubiquitin-dependent proteolysis in vertebrate photoreceptors (rod outer segments). Evidence for ubiquitinylation of Gt and rhodopsin.
    Obin MS; Jahngen-Hodge J; Nowell T; Taylor A
    J Biol Chem; 1996 Jun; 271(24):14473-84. PubMed ID: 8662797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes.
    Stancovski I; Gonen H; Orian A; Schwartz AL; Ciechanover A
    Mol Cell Biol; 1995 Dec; 15(12):7106-16. PubMed ID: 8524278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts.
    Salvat C; Jariel-Encontre I; Acquaviva C; Omura S; Piechaczyk M
    Oncogene; 1998 Jul; 17(3):327-37. PubMed ID: 9690514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cellular and viral Fos proteins.
    Acquaviva C; Ferrara P; Bossis G; Brockly F; Salvat C; Jariel-Encontre I; Piechaczyk M
    Biochimie; 2001; 83(3-4):357-62. PubMed ID: 11295497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex mechanisms for c-fos and c-jun degradation.
    Jariel-Encontre I; Salvat C; Steff AM; Pariat M; Acquaviva C; Furstoss O; Piechaczyk M
    Mol Biol Rep; 1997 Mar; 24(1-2):51-6. PubMed ID: 9228281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo?
    Salvat C; Aquaviva C; Jariel-Encontre I; Ferrara P; Pariat M; Steff AM; Carillo S; Piechaczyk M
    Mol Biol Rep; 1999 Apr; 26(1-2):45-51. PubMed ID: 10363646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple degradation pathways for Fos family proteins.
    Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
    Ann N Y Acad Sci; 2002 Nov; 973():426-34. PubMed ID: 12485905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Fos proto-oncoprotein is degraded by the proteasome independently of its own ubiquitinylation in vivo.
    Bossis G; Ferrara P; Acquaviva C; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2003 Oct; 23(20):7425-36. PubMed ID: 14517309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted degradation of c-Fos, but not v-Fos, by a phosphorylation-dependent signal on c-Jun.
    Papavassiliou AG; Treier M; Chavrier C; Bohmann D
    Science; 1992 Dec; 258(5090):1941-4. PubMed ID: 1470918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun.
    Leonard DA; Rajaram N; Kerppola TK
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4913-8. PubMed ID: 9144164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    Fang S; Jensen JP; Ludwig RL; Vousden KH; Weissman AM
    J Biol Chem; 2000 Mar; 275(12):8945-51. PubMed ID: 10722742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly.
    Abate C; Luk D; Gentz R; Rauscher FJ; Curran T
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1032-6. PubMed ID: 2105492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitination and degradation of ATF2 are dimerization dependent.
    Fuchs SY; Ronai Z
    Mol Cell Biol; 1999 May; 19(5):3289-98. PubMed ID: 10207054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
    Pagano M; Tam SW; Theodoras AM; Beer-Romero P; Del Sal G; Chau V; Yew PR; Draetta GF; Rolfe M
    Science; 1995 Aug; 269(5224):682-5. PubMed ID: 7624798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-mediated protein modification and degradation.
    Schwartz AL; Ciechanover A
    Am J Respir Cell Mol Biol; 1992 Nov; 7(5):463-8. PubMed ID: 1329865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome.
    Jariel-Encontre I; Pariat M; Martin F; Carillo S; Salvat C; Piechaczyk M
    J Biol Chem; 1995 May; 270(19):11623-7. PubMed ID: 7744802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination is required for the retro-translocation of a short-lived luminal endoplasmic reticulum glycoprotein to the cytosol for degradation by the proteasome.
    de Virgilio M; Weninger H; Ivessa NE
    J Biol Chem; 1998 Apr; 273(16):9734-43. PubMed ID: 9545309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun NH2-terminal kinases target the ubiquitination of their associated transcription factors.
    Fuchs SY; Xie B; Adler V; Fried VA; Davis RJ; Ronai Z
    J Biol Chem; 1997 Dec; 272(51):32163-8. PubMed ID: 9405416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.